3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Sarcoma
14
Ovarian Neoplasms
6
Neoplasms
5
Liposarcoma
5
Leiomyosarcoma
5
Liposarcoma, Myxoid
3
Breast Neoplasms
3
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Prostatic Neoplasms
2
Osteosarcoma
2
Neoplasms by Site
2
Neoplasm Metastasis
2
Mesothelioma, Malignant
2
Ichthyosis, X-Linked
2
Endometrial Neoplasms
2
Uterine Neoplasms
1
Solitary Fibrous Tumors
1
Soft Tissue Neoplasms
1
Skin Diseases
1
Sarcoma, Synovial
1
Sarcoma, Endometrial Stromal
1
Sarcoma, Alveolar Soft Part
1
Recurrent High Grade Meningioma
1
Pancreatic Neoplasms
1
Ovarian Diseases
1
Neurofibrosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Mesothelioma
1
Malignant mesenchymal tumor
1
Interventions
Gemcitabine
295
Fluorouracil
82
Oxaliplatin
81
130-nm albumin-bound paclitaxel
68
Capecitabine
60
Leucovorin
56
Albumin-Bound Paclitaxel
54
Radiotherapy
51
Irinotecan
44
Taxes
37
Cisplatin
36
Erlotinib Hydrochloride
34
Radiosurgery
33
pembrolizumab
29
Docetaxel
27
S 1 (combination)
26
Bevacizumab
23
folfirinox
22
Nivolumab
21
Magnetic Resonance Spectroscopy
17
Cyclophosphamide
17
Cetuximab
17
irinotecan sucrosofate
16
Radiation
16
Drug Therapy
15
Surgical Procedures, Operative
14
Specimen Handling
11
Biopsy
11
durvalumab
10
Paclitaxel
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Pancreatic Neoplasms
×
Trabectedin
×
Clear all
NCT01339754
2014-08-11
PACT-18
IRCCS San Raffaele
Phase 2
Completed
25 enrolled